Biocon has entered into academic partnership with Trinity College of Dublin. Indian students are to benefit from a new international scholarship fund that will support innovative genetics research taking place at Ireland's leading university, Trinity College Dublin, the University of Dublin, (www.tcd.ie).
Biocon, Asia's premier biotechnology company, has agreed to sponsor two annual scholarships to Trinity College Dublin that will give Indian students who demonstrate creativity, motivation and academic excellence the opportunity to travel to Ireland to work in top laboratories in Trinity College Dublin. The announcement was made during the largest-ever education mission to India, led by Minister for Training and Skills, Ciaran Cannon TD, organised by Enterprise Ireland.
Biocon is India's premier biotechnology company with a strategic focus on biopharmaceuticals and research services. Biocon produces anti-diabetic agents like Acarbose, Pioglitazone, Repaglinides and Rosiglitazone. In the biological segment it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), Streptokinase and Monoclonal Antibodies.